43
Participants
Start Date
October 29, 2021
Primary Completion Date
March 13, 2025
Study Completion Date
May 21, 2025
AB-729
subcutaneous injection
Peg-IFNα-2a
subcutaneous injection
Arensia Exploratory Medicine Moldova, Chisinau
Nepean Hospital, Kingswood
St Vincent's Hospital Melbourne, Melbourne
University of Miami Miller School of Medicine, Miami
Henry Ford Health System, Detroit
Pusan National University Hospital, Pusan
Chia-Yi Christian Hospital, Chiayi City
Chung-Ho Memorial Hospital, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Arizona Liver Health, Chandler
Arizona Liver Health, Tucson
Research and Education, Inc., San Diego
ID Care, Hillsborough
Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
Queen Mary Hospital, Hong Kong
Asan Medical Center, Seoul
Medical Center of Limited Liability Company Harmoniya Krasy, Kyiv
Lead Sponsor
Arbutus Biopharma Corporation
INDUSTRY